GL CHEMTEC (“GLC”) has announced the launch of a new visual brand and website. The new visual identity arrives at a pivotal moment in the company's journey, aligning with GLC's remarkable growth. This growth has been bolstered by an already established cutting-edge analytical lab specializing in the characterization and release of small molecules and polymers, ongoing expansions to the company’s state-of-the-art scale-up laboratory and pilot plant facilities, and the formation of the GLC Scientific Advisory Board. All of this in partnership with Edgewater Capital Partners to accelerate long-term growth.
The revitalized brand introduces a modern logo and contemporary colour palette to signify the company's evolution, while maintaining a connection to a rich 22-year company history by anchoring in the original teal colour. The logo's stylized molecule visually represents GLC's two core capabilities and integrated solutions offering, combining two specialized areas of expertise under one unified brand. The refreshed visual identity encompasses the company’s core values of innovation, integrity, collaboration, and agility.
The elevated design of the new GLC website reflects the company’s unique position as a highly differentiated, specialty CDMO in North America. It showcases the company’s state-of-the-art facilities and innovative services, which apart from small molecule API development, include strong organic polymer expertise and advanced biomedical materials applied to medical devices, drug delivery, and ophthalmic applications such as next-generation contact lenses.
“GL CHEMTEC's refreshed visual identity and new website reflect a new era of growth while maintaining our commitment to our mission. It highlights our unique position in the market and builds on our 22-year history, emphasizing our ongoing commitment to solving complex chemistry challenges and providing innovative solutions,” said Lisa Studnicki Hunt, Ph.D., COO and Co-Founder of GLC.
Over the last two decades, GLC has established itself as a leader in the life sciences sector, delivering sustainable, innovative solutions with unparalleled speed and passion. The company’s track record of success is rooted in an unwavering commitment to their customers and their unique ability to adapt to diverse needs through a flexible, collaborative approach. Located in North America, GLC provides a secure supply chain, enabling accelerated early-stage API development and the seamless transition of innovative drug delivery solutions from research and development to manufacturing.
GLC is ISO 13485:2016 and ISO 9001:2015 certified, and has been granted numerous awards over the years, including Bell Mid-Sized Business of the Year (2017), Canadian Business Review Board Best Business Award (2021, 2022, 2023, 2024), and Winner Magazine - Outstanding Canadian Business (2023).